CIBC Deal Ends Hedge Fund's Pharma Stock Spoofing Suit
A lawsuit accusing major banks of manipulating a former Canadian pharmaceutical company's stock and inflicting millions in losses on a hedge fund is drawing to a close after more than five...To view the full article, register now.
Already a subscriber? Click here to view full article